OrphanDrug
OrphanDrug
Pharma Knowledge Base
TJ

Tajikistan

TJ

Central Asia

Contents

  1. 1. Regulatory Overview
  2. 2. Regulatory Pathways

Regulatory Overview

Tajikistan is regulated by the Ministry of Health. The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

Ministry of Health

Regulatory Pathways (1)

Tajikistan MOH Special Import Authorization 45 days

Tajikistan Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Tajikistan Special Import Form
Legal Basis: Regulated
Eligibility: Serious or life-threatening condition with no locally registered alternative
TJ
Tajikistan
ISO CodeTJ
RegionCentral Asia
Regulatory AuthorityMinistry of Health
Pathways1 documented
Drugs Available0 documented
Tajikistan — Drug Regulatory Pathways & Orphan Drug Access | OrphanDrug